Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Oncology Institute (TOI) Return on Equity (2020 - 2025)

Historic Return on Equity for Oncology Institute (TOI) over the last 6 years, with Q3 2025 value amounting to 6.24%.

  • Oncology Institute's Return on Equity rose 93800.0% to 6.24% in Q3 2025 from the same period last year, while for Sep 2025 it was 6.24%, marking a year-over-year increase of 93800.0%. This contributed to the annual value of 2.13% for FY2024, which is 12100.0% down from last year.
  • Latest data reveals that Oncology Institute reported Return on Equity of 6.24% as of Q3 2025, which was up 93800.0% from 33.65% recorded in Q2 2025.
  • Over the past 5 years, Oncology Institute's Return on Equity peaked at 33.65% during Q2 2025, and registered a low of 14.87% during Q1 2025.
  • Over the past 5 years, Oncology Institute's median Return on Equity value was 0.39% (recorded in 2021), while the average stood at 0.39%.
  • Data for Oncology Institute's Return on Equity shows a peak YoY increase of 356800bps (in 2025) and a maximum YoY decrease of -133800bps (in 2025) over the last 5 years.
  • Oncology Institute's Return on Equity (Quarter) stood at 0.14% in 2021, then surged by 101bps to 0.0% in 2022, then plummeted by -106585bps to 1.29% in 2023, then plummeted by -426bps to 6.78% in 2024, then surged by 192bps to 6.24% in 2025.
  • Its Return on Equity was 6.24% in Q3 2025, compared to 33.65% in Q2 2025 and 14.87% in Q1 2025.